المؤلفون: Irene M, Shui, Emilie, Scherrer, Andrew, Frederickson, Joyce W, Li, Anel, Mynzhassarova, Eric, Druyts, Hussein, Tawbi

المصدر: Melanoma Research. 32:393-404

مصطلحات موضوعية: Cancer Research, Skin Neoplasms, Oncology, Drug Resistance, Neoplasm, Programmed Cell Death 1 Receptor, Humans, Immunotherapy, Dermatology, Ipilimumab, Melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24277db8ff02d4b150d4a28e6f90efe7Test
https://doi.org/10.1097/cmr.0000000000000850Test

المؤلفون: Arielle G. Bensimon, Wei Gao, Madeline Jenkins, Emilie Scherrer, James Signorovitch, Raquel Aguiar-Ibáñez, Zheng-Yi Zhou, Clemens Krepler, Jingshu Wang, Yan Song

المصدر: Clinical Drug Investigation

مصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, medicine.medical_treatment, Cost-Benefit Analysis, Population, Ipilimumab, Pembrolizumab, 030204 cardiovascular system & hematology, Placebo, Antibodies, Monoclonal, Humanized, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, Adverse effect, education, Melanoma, Neoplasm Staging, Trametinib, education.field_of_study, business.industry, Dabrafenib, General Medicine, Health Care Costs, Middle Aged, Female, Quality-Adjusted Life Years, business, Adjuvant, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc665ba8e733bfe3fa1a444a1858bd33Test
https://pubmed.ncbi.nlm.nih.gov/32418051Test

المؤلفون: Todd A. Lee, Frank Xiaoqing Liu, Alicia C. Shillington, Emilie Scherrer, Vaidehi Dave, Scott J. Diede, Richard W. Joseph, Qing Harshaw, Cynthia Macahilig

المصدر: Journal of medical economics. 23(2)

مصطلحات موضوعية: Oncology, Male, Skin Neoplasms, medicine.medical_treatment, Pembrolizumab, Comorbidity, Severity of Illness Index, 0302 clinical medicine, Antineoplastic Agents, Immunological, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Melanoma, Aged, 80 and over, 030503 health policy & services, Health Policy, Age Factors, Health Services, Middle Aged, Hospitalization, Nivolumab, 030220 oncology & carcinogenesis, Health Resources, Female, 0305 other medical science, Emergency Service, Hospital, medicine.drug, Adult, medicine.medical_specialty, Ipilimumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Sex Factors, Internal medicine, medicine, Humans, Advanced melanoma, Aged, Neoplasm Staging, Retrospective Studies, business.industry, Immunotherapy, Emergency department, medicine.disease, Regimen, Socioeconomic Factors, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea03f3e3d324c5e59f46dbc80ab03ca2Test
https://pubmed.ncbi.nlm.nih.gov/31750751Test